Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009.
BACKGROUND
In April 2009, a novel triple-reassortant swine influenza A H1N1 virus ("A/H1N1pdm"; also known as SOIV) was detected and spread globally as the first influenza pandemic of the 21(st) century. Sequencing has since been conducted at an unprecedented rate globally in order to monitor the diversification of this emergent virus and to track mutations that may affect virus behavior.


RESULTS
By Sanger sequencing, we determined consensus whole-genome sequences for A/H1N1pdm viruses sampled nationwide in Canada over 33 weeks during the 2009 first and second pandemic waves. A total of 235 virus genomes sampled from unique subjects were analyzed, providing insight into the temporal and spatial trajectory of A/H1N1pdm lineages within Canada. Three clades (2, 3, and 7) were identifiable within the first two weeks of A/H1N1pdm appearance, with clades 5 and 6 appearing thereafter; further diversification was not apparent. Only two viral sites displayed evidence of adaptive evolution, located in hemagglutinin (HA) corresponding to D222 in the HA receptor-binding site, and to E374 at HA2-subunit position 47. Among the Canadian sampled viruses, we observed notable genetic diversity (1.47 x 10⁻³ amino acid substitutions per site) in the gene encoding PB1, particularly within the viral genomic RNA (vRNA)-binding domain (residues 493-757). This genome data set supports the conclusion that A/H1N1pdm is evolving but not excessively relative to other H1N1 influenza A viruses. Entropy analysis was used to investigate whether any mutated A/H1N1pdm protein residues were associated with infection severity; however no virus genotypes were observed to trend with infection severity. One virus that harboured heterozygote coding mutations, including PB2 D567D/G, was attributed to a severe and potentially mixed infection; yet the functional significance of this PB2 mutation remains unknown.


CONCLUSIONS
These findings contribute to enhanced understanding of Influenza A/H1N1pdm viral dynamics.
National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. morag.graham@phac-aspc.gc.ca
Morag
M
Graham
Binhua
B
Liang
Gary
G
Van Domselaar
Nathalie
N
Bastien
Carole
C
Beaudoin
Shaun
S
Tyler
Brynn
B
Kaplen
Erika
E
Landry
Yan
Y
Li
D002170:Canada / Q000453:epidemiology; D016679:Genome, Viral; D006579:Heterozygote; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics*; D007251:Influenza, Human / Q000453:epidemiology*; D008969:Molecular Sequence Data; D009154:Mutation; D058873:Pandemics; D011159:Population Surveillance
Antiviral Res. 2008 Sep;79(3):166-78
18547656
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70
19918065
Mol Biol Evol. 2005 May;22(5):1208-22
15703242
Virus Res. 2002 May 10;85(2):199-210
12034486
Annu Rev Microbiol. 2008;62:403-24
18785841
Science. 2009 Jul 10;325(5937):197-201
19465683
JAMA. 2009 Nov 4;302(17):1872-9
19822627
PLoS One. 2009 Nov 17;4(11):e7789
19924230
Microbiol Rev. 1992 Mar;56(1):152-79
1579108
J Virol. 2009 Sep;83(17):8832-41
19553313
J Virol. 2005 Dec;79(23):14933-44
16282492
Nature. 2009 Jun 25;459(7250):1122-5
19516283
Science. 2007 Feb 2;315(5812):655-9
17272724
PLoS One. 2009 May 21;4(5):e5658
19462010
Bioinformatics. 2010 Jun 15;26(12):1569-71
20421198
PLoS Pathog. 2010 Jul 22;6(7):e1001015
20661429
PLoS Pathog. 2006 Dec;2(12):e125
17140286
Virology. 2010 Sep 30;405(2):314-21
20598336
Bioinformatics. 2007 Nov 1;23(21):2947-8
17846036
Virus Res. 2010 Aug;151(2):192-9
20493216
J Virol. 2010 Sep;84(17):8691-9
20573828
PLoS Curr. 2010 Mar 22;2:RRN1152
20352039
Vet Res. 2010 Nov-Dec;41(6):38
20167200
PLoS Curr. 2010 Jun 01;2:RRN1162
20535229
Virologie (Montrouge). 2006 Aug 1;10(4):301-309
34731995
J Virol. 2000 Jul;74(14):6538-45
10864667
Nature. 2008 May 29;453(7195):615-9
18418375
Science. 2009 Apr 10;324(5924):246-51
19251591
PLoS One. 2010 Jan 01;5(1):e8553
20049332
Virology. 2001 Mar 1;281(1):102-8
11222100
PLoS Comput Biol. 2007 Nov;3(11):e231
18039027
PLoS Curr. 2009 Nov 03;1:RRN1126
20029664
J Virol. 2006 Apr;80(7):3675-8
16537638
J Virol. 2002 Sep;76(17):8757-68
12163596
Virol J. 2007 Dec 05;4:134
18053252
Cell Cycle. 2010 Mar 1;9(5):958-70
20160492
Acta Biochim Biophys Sin (Shanghai). 2007 Mar;39(3):155-62
17342253
Glycobiology. 1992 Jun;2(3):233-40
1379858
PLoS One. 2010 Mar 15;5(3):e9693
20300625
J Mol Biol. 2006 Feb 3;355(5):1143-55
16343533
Euro Surveill. 2010 Mar 04;15(9):
20214869
PLoS Pathog. 2008 Feb 8;4(2):e11
18248089
Arch Virol. 2001 Dec;146(12):2275-89
11811679
Biochem Cell Biol. 2010 Aug;88(4):589-93
20651829
Bioinformatics. 2009 May 1;25(9):1189-91
19151095
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6
19995968
Curr Opin Struct Biol. 2010 Feb;20(1):104-13
20061134
PLoS One. 2010 Feb 03;5(2):e9025
20140252
Virol J. 2009 May 29;6:67
19476650
PLoS Pathog. 2008 Aug 29;4(8):e1000136
18769709
CMAJ. 2009 Aug 4;181(3-4):159-63
19620268
N Engl J Med. 2010 May 6;362(18):1708-19
20445182
Heredity (Edinb). 2011 Feb;106(2):383-90
20551981
Nat Struct Mol Biol. 2010 May;17(5):530-8
20383144
Brief Bioinform. 2008 Jul;9(4):299-306
18417537
Biol Direct. 2009 May 20;4:18; discussion 18
19457254
Comput Appl Biosci. 1996 Aug;12(4):357-8
8902363